Nautilus Biotechnology
3 known investors
Nautilus develops proteomics technology to unlock the complexity of the human proteome for biomedical research and diagnostics. The company targets pharmaceutical, biotechnology, academic, clinical, and government sectors with advanced protein quantification and analysis platforms.
Founders & leadership
SP
Sujal PatelFounder & CEO
PM
Parag MallickFounder & Chief Scientist
Investors · 3
In the news
- Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com · 2026
- Nautilus Biotechnology - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- Nautilus Biotechnology Raises $76M in Series B Funding - FinSMEsfinsmes.com · 2020
- Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human Proteome - BioSpacebiospace.com · 2020